Key facts
| Price (PPV) | 40.70 MAD |
|---|---|
| Composition (DCI) | cyproheptadine |
| Class | Antihistamines for systemic use |
| ATC code | R06AX02 |
| Manufacturer | GALENICA |
| Presentation | Boîte de 90 |
| Nature | Médicament |
| Hospital price | 25.40 MAD |
| Data collected on | 9/8/2026 |
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Nurabol 4 mg (PHARMA5) contains the same active substance as Apetine 4 mg (Cyproheptadine) at the same strength, but in a different pack: Boîte de 30 at 14.20 MAD, i.e. 0.47 MAD per unit against 0.45 MAD for Apetine 4 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Pernabol 4 mg | GALENICA | Boîte de 90 | 40.70 MAD | 0.45 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Nurabol 4 mg | PHARMA5 | Boîte de 30 | 14.20 MAD | 0.47 / unit |
| Apetine 4 mg | GALENICA | Boîte de 30 | 15.20 MAD | 0.51 / unit |
| Pernabol 4 mg | GALENICA | Boîte de 30 | 15.70 MAD | 0.52 / unit |
| Antinorex 4 mg | LAPROPHAN | Boîte de 30 | 16 MAD | 0.53 / unit |
| Aractine 4 mg | POLYMEDIC | Boîte de 30 | 16.10 MAD | 0.54 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Apetine 4 mg
Apetine 4 mg belongs to the antihistamines for systemic use therapeutic class. In Morocco, this drug is marketed by GALENICA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Apetine 4 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Apetine 4 mg
Answers to common questions from Moroccan patients about this drug.